We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XWhite Paper
September 27, 2016
Recent device launches in hypercholesterolemia therapy and for biosimilars have highlighted the increasing importance of auto-injectors as a drug delivery method. SHL Group’s Dr Thomas Schönknecht offers insight into prefillable syringes, glass handling and final assembly challenges.
Download to find out more.